General Information of the Compound
Compound ID |
CP0404841
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-[5-(3-Bromo-furan-2-yl)-[1,2,4]oxadiazol-3-yl]-5-chloro-pyridine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C11H5BrClN3O2
|
||||||||||||||||||
Molecular Weight |
326.537
|
||||||||||||||||||
Canonical SMILES |
Clc1ccc(nc1)-c1noc(n1)-c1occc1Br
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C11H5BrClN3O2/c12-7-3-4-17-9(7)11-15-10(16-18-11)8-2-1-6(13)5-14-8/h1-5H
Show/Hide
|
||||||||||||||||||
InChIKey |
HNLXMMPRJSANGA-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01014, Caspase-3
Cell Viability or Cytotoxicity Assay